XIMANDER Trademark

Trademark Overview

On Thursday, May 15, 2014, a trademark application was filed for XIMANDER with the United States Patent and Trademark Office. The USPTO has given the XIMANDER trademark a serial number of 86282276. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2024. This trademark is owned by Glaxo Group Limited. The XIMANDER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

General Information

Serial Number86282276
Word MarkXIMANDER
Filing DateThursday, May 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2024
Registration Number5430685
Registration DateTuesday, March 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, May 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 29, 2014ASSIGNED TO EXAMINER
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 19, 2014NEW APPLICATION ENTERED
Friday, August 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, May 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 16, 2015SOU TEAS EXTENSION RECEIVED
Monday, November 16, 2015SOU EXTENSION 2 FILED
Thursday, April 30, 2015SOU TEAS EXTENSION RECEIVED
Thursday, April 30, 2015SOU EXTENSION 1 FILED
Thursday, April 30, 2015SOU EXTENSION 1 GRANTED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 8, 2015SOU EXTENSION 2 GRANTED
Thursday, May 26, 2016SOU EXTENSION 3 FILED
Wednesday, July 13, 2016SOU EXTENSION 3 GRANTED
Thursday, July 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 17, 2016SOU EXTENSION 4 GRANTED
Monday, December 7, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 26, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 1, 2016SOU EXTENSION 4 FILED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 25, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, November 29, 2017ASSIGNED TO PETITION STAFF
Monday, December 4, 2017CASE RETURNED TO EXAMINATION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 25, 2017SOU EXTENSION 5 FILED
Tuesday, May 30, 2017SOU EXTENSION 5 GRANTED
Thursday, November 30, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, December 4, 2017NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 11, 2024CANCELLED SEC. 8 (6-YR)
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

ximander pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological